ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
---|---|---|---|
C0037868 | Mature male germ cells derived from SPERMATIDS. As spermatids move toward the lumen of the SEMINIFEROUS TUBULES, they undergo extensive structural changes including the loss of cytoplasm, condensation of CHROMATIN into the SPERM HEAD, formation of the ACROSOME cap, the SPERM MIDPIECE and the SPERM TAIL that provides motility. | Androcyte|cells sperms|androcyte|sperm cell|Spermatozoa (cell)|spermatozoon|sperms|cell sperm|Spermatic|Mature sperm cell|Sperm|Spermium|Spermatozoon|sperm|Zoosperm|spermium|Sperm cell|spermatozoa|SPERMATOZOON|cells sperm|zoosperm|Sperm Cell|Spermatozoa | sperm cell |
C0017861 | A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent. | Propanetriol|Glycerol (substance)|Product containing glycerol (medicinal product)|1,2,3-propanetriol|Glycerin-containing product|Glycerol-containing product|1,2,3-Trihydroxypropane|Trihydroxypropane|glycerine|1,2,3-trihydroxypropane|Glycerin|Glycerinum|glycerin|glycerol|glycérine|Glyzerin|glycérol|Monoctanoin component D|Glycerol|Glycerine|GLycerin|GLYCERIN|1,2,3-Propanetriol|Ölsüß | glycerin |
C1159339 | The controlled release of proteins from a cell. [GOC:ai] | protein secretion | Protein Secretion |
C0032043 | A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). | Placenta|Placentomes|Placentas|Placental|Placentomes (body structure)|placentas|Placental structure (body structure)|placentome|Placental structure|Placenta, NOS|PLACENTA|placenta|Placentome | Placenta |
C0015965 | The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. | FETUS|fetus|Fetal|Fetuses|Fetus | Fetus |
C0034580 | Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. | RIA|Radioimmunoassay|radioimmunoassay (RIA)|Radioimmunoassay (procedure)|ria|Radioimmunoassays|RIA test|radioimmunoassays|radioimmunoassay|Immunologic, Radioimmunoassay|Radioimmunoassay technique|Radioimmunoassay test|Radioimmunoassay, NOS|Radioimmunoassay technique (qualifier value) | Radioimmunoassay |
C0017968 | Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins. | Glycoproteins|Glycoprotein|glycoprotein|Glycoprotein, NOS|Glycoprotein (substance)|glycoproteins | Glycoproteins |
C1522642 | An identical copy of a DNA sequence or entire gene; one or more cells derived from and identical to a single ancestor cell OR to isolate a gene or specific sequence of DNA. | Clone|Clonal|clone | Clone |
C0017968 | Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins. | Glycoproteins|Glycoprotein|glycoprotein|Glycoprotein, NOS|Glycoprotein (substance)|glycoproteins | Glycoproteins |
C0018270 | Gradual increase in the number, the size, and the complexity of cells of an individual. Growth generally results in increase in ORGAN WEIGHT; BODY WEIGHT; and BODY HEIGHT. | normal growth|ontogeny|Growth|growth|growths|embryonic growth?|GROWTH|biological growth|Generalized Growth|physical growth|physical growth process | Growth |
C0025252 | Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. | Membrane proteins|Protein, Membrane|Membrane Protein|Proteins, Membrane|surface proteins|Surface Proteins|membrane protein|Membrane-Associated Proteins|Proteins, Membrane-Associated|surface protein|membrane proteins|protein surface|Proteins, Surface|Membrane Associated Proteins | Membrane Proteins |
C0872318 | LC/MS is a hyphenated technique, combining the separation power of liquid chromatography (LC), an analytical chromatographic technique for separating ions or molecules dissolved in a solvent, with the detection power of mass spectrometry(MS), a technique to separate gas phase ions according their m/z (mass to charge ratio) value. Used for drug screening, pharmacology studies, environmental analyses and forensics. | Liquid Chromatography Mass Spectrometry|Liquid Chromatography/Mass Spectrometry|liquid chromatography mass spectrometry|LCMS|LC/MS|Liquid Chromatography-Mass Spectrometry | Liquid Chromatography Mass Spectrometry |
C0205148 | The extended two-dimensional outer boundary of a three-dimensional object. | Surface (qualifier value)|Surface|surface|SURFACE|Surface (attribute) | Surface |
C0016055 | Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. | Glycoprotein, Opsonic|alpha 2 Surface Binding Glycoprotein|Cold Insoluble Globulins|fibronectins|LETS Proteins|Opsonic Glycoprotein|Cold-Insoluble Globulins|Proteins, LETS|Globulins, Cold-Insoluble|Opsonic alpha(2)SB Glycoprotein|Fibronectin|cold-insoluble globulins|Fibronectins|cold insoluble globulin|LETS protein|fibronectin|Fibronectin (substance)|alpha 2-Surface Binding Glycoprotein | Fibronectins |
C1257792 | null | Endothelial Cell, Vascular|Vascular Endothelial Cell|Cell, Vascular Endothelial|Cells, Vascular Endothelial|Endothelial Cells, Vascular | Vascular Endothelial Cells |
C1151872 | Catalysis of the reaction: E1 + ubiquitin + ATP--> E1-ubiquitin + AMP + PPi, where the E1-ubiquitin linkage is a thioester bond between the C-terminal glycine of Ub and a sulfhydryl side group of an E1 cysteine residue. This is the first step in a cascade of reactions in which ubiquitin is ultimately added to a protein substrate. [GOC:BioGRID, http://www.bostonbiochem.com/E-301.html, Wikipedia:Ubiquitin-activating_enzyme] | ubiquitin activating enzyme activity|E1 ubiquitin-activating enzyme | ubiquitin-activating enzyme activity |
C1139930 | null | plates|plate | Device Plate |
C0015421 | A pair of ophthalmic lenses in a frame or mounting which is supported by the nose and ears. The purpose is to aid or improve vision. It does not include goggles or nonprescription sun glasses for which EYE PROTECTIVE DEVICES is available. | Eye glasses, device (physical object)|spectacle|eyeglass|spectacles|Spectacles|Eye glasses, device|eye glasses|eyeglasses|Eye glasses|Eyeglasses|Glasses|glasses | Eyeglasses |
C0332479 | The spatial arrangement of something as distinct from its substance. | SHAPES|Shape|Shape finding (qualifier value)|SHAPE|shaped|shapes|Shape finding|shaping|shape|Shapes | Shapes |
C0006353 | A chemical system that functions to control the levels of specific ions in solution. When the level of hydrogen ion in solution is controlled the system is called a pH buffer. | Buffered|chemical buffer|buffer|Buffer|buffers | Buffers |
C0596630 | small nerve cell bodies found in the brain; do not confuse with GRANULE, a cell component found in many cell types. | null | granule cell |
C0043775 | null | BAPTA|Glycine, N,N'-(1,2-ethanediylbis(oxy-2,1-phenylene))bis(N-(carboxymethyl))-,tetrapotassium salt|1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid|BAPETA | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid |
C0108793 | GPI-linked membrane proteins broadly distributed among hematopoietic and non-hematopoietic cells. CD55 prevents the assembly of C3 CONVERTASE or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex. | Decay accelerating factor|DAF - Decay accelerating factor|decay accelerating factor|CD55 Antigens|CD55 Antigen|daf|Cluster of differentiation antigen 55|CD55 antigen|CD55 - Cluster of differentiation antigen 55|Decay-Accelerating Factor, Complement|Complement Decay Accelerating Factor|Decay accelerating factor (substance)|Lymphocyte antigen CD55|Complement Decay-Accelerating Factor|Decay-Accelerating Factor|DAF|Decay Accelerating Factor|Antigens, CD55|CD55 | Antigens, CD55 |
C0108793 | GPI-linked membrane proteins broadly distributed among hematopoietic and non-hematopoietic cells. CD55 prevents the assembly of C3 CONVERTASE or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex. | Decay accelerating factor|DAF - Decay accelerating factor|decay accelerating factor|CD55 Antigens|CD55 Antigen|daf|Cluster of differentiation antigen 55|CD55 antigen|CD55 - Cluster of differentiation antigen 55|Decay-Accelerating Factor, Complement|Complement Decay Accelerating Factor|Decay accelerating factor (substance)|Lymphocyte antigen CD55|Complement Decay-Accelerating Factor|Decay-Accelerating Factor|DAF|Decay Accelerating Factor|Antigens, CD55|CD55 | Antigens, CD55 |
C0054444 | A group of proteins that bind calcium and move it into cells. Calbindins are found in many different tissues in the body | Calbindins|Calbindin|calbindin | Calbindins |
C0054444 | A group of proteins that bind calcium and move it into cells. Calbindins are found in many different tissues in the body | Calbindins|Calbindin|calbindin | Calbindins |
C0030281 | A cell that composes the bulk of the islets of Langerhans and secretes insulin. | beta Cell, Pancreatic|Insulin-secreting cell|Type B enteroendocrine cell|beta Cells, Pancreatic|Insulin-Secreting Cell|Pancreatic B Cells|Cells, Insulin-Secreting|Pancreatic beta cell|Type B pancreatic cell|Pancreatic B Cell|B-cell of pancreatic islet|pancreatic beta cells|pancreas beta cell|B Cell, Pancreatic|Pancreatic beta cells|Pancreatic B-cell|B Cells, Pancreatic|beta Cell of islet|Insulin Secreting Cell|Beta cell of pancreatic islet|Type B cell of pancreatic islet|pancreatic beta cell|Beta cell|Beta Cell|Insulin Cell|Structure of beta cell of islet (cell structure)|Insulin-Secreting Cells|Structure of beta cell of islet|Pancreatic beta Cell|Pancreatic beta Cells|Beta cell of islet|Insulin Secreting Cells|Cell, Insulin-Secreting | Structure of beta Cell of islet |
C0220821 | partially saturated derivative of pyridine; binds to and inhibits the voltage-gated calcium channel of skeletal muscle T junctional membranes, the principle molecular transducer of excitation-contraction coupling. | DHP|1,4-dihydropyridine|dihydropyridine|dhp|dhps | dihydropyridine |
C0054444 | A group of proteins that bind calcium and move it into cells. Calbindins are found in many different tissues in the body | Calbindins|Calbindin|calbindin | Calbindins |
C0042523 | A calcium channel blocker that is a class IV anti-arrhythmia agent. | Verapamil|Verapamilum|Verapamilo|Product containing verapamil (medicinal product)|Iproveratril|Verapamil-containing product|Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-|VERAPAMIL|alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile|Verapamil (substance)|verapamil|Vérapamil | verapamil |
C0333717 | An abnormal human cell type which can occur in either disease states or disease models. | Cytologic abnormality|Cytologic alteration|Abnormal Cell|abnormal cells|Abnormal cell, NOS|cell abnormal|Abnormal cell (cell)|Cytologic Alteration|abnormal cell|Abnormal cell | Abnormal cell |
C0016540 | The part of the face above the eyes. | Foreheads|FOREHEAD|Forehead, NOS|Forehead|Frons|Sinciput|Forehead structure|foreheads|forehead|Forehead structure (body structure) | Forehead |
C0935989 | An antineoplastic agent that inhibits the Bcr-Abl fusion protein tyrosine kinase, an abnormal enzyme produced by chronic myeloid leukemia cells that contain the Philadelphia chromosome. Imatinib also inhibits the receptor tyrosine kinases for platelet-derived growth factor (PDGF) and stem cell factor (SCF)/c-kit; the SCF/c-kit receptor tyrosine kinase is activated in gastrointestinal stromal tumor (GIST). This agent inhibits proliferation and induces apoptosis in cells that overexpress these oncoproteins. | Imatinib-containing product|IMATINIB|4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide|imatinib|Product containing imatinib (medicinal product)|Imatinib|Imatinib (substance)|Imatinibum|α-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide|Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide | imatinib |
C0040808 | A treatment plan that specifies the dosage, the schedule, and the duration of treatment. | protocol treatment|Treatment Protocols|Treatment Regimen|Protocols, Treatment|Treatment Protocol|regimen|Regimen|Treatment Schedule|treatment protocols|protocols treatment|treatment protocol | Treatment Protocols |
C0024301 | Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES. | Malignant lymphoma, centroblastic-centrocytic, follicular (disorder)|Follicular Lymphomas, Giant|Follicular Non-Hodgkin's Lymphoma|Nodular lymphoma|Malignant lymphoma, lymphocytic, nodular|Lymphomas, Nodular|Follicular Centre Cell Lymphoma|Giant follicular lymphosarcoma|Nodular Lymphomas|Malignant lymphoma, nodular|Malignant lymphoma, follicle center, follicular|Malignant lymphoma, follicle centre|Lymphoma, Follicular Centre Cell|lymphoma follicular|Follicular Lymphoma, Giant|Follicular Lymphomas|Malignant lymphoma, nodular, NOS|Brill-Symmers disease|Lymphomas, Follicular|Nodular lymphoma (disorder)|Brill-Symmers' disease|Giant Follicular Lymphomas|Malignant lymphoma, follicular|Disease, Brill-Symmers|Malignant lymphoma, centroblastic-centrocytic, follicular|Giant follicular lymphoma|follicular non-Hodgkin's lymphoma|follicular non-Hodgkin lymphoma|Follicular lymphoma (morphologic abnormality)|Nodular lymphocytic lymphoma|follicle center lymphoma|Brill-Symmers Disease|Germinoblastoma, follicular|Lymphoma, Giant Follicular|Follicle Center Lymphoma|Lymphomas, Giant Follicular|Giant Follicular Lymphoma|LYMPHOMA, FOLLICULAR, MALIGNANT|Follicular Lymphoma|follicular lymphomas|Nodular malignant lymphoma|Malignant lymphoma, follicular, NOS|Lymphoma, Follicular|nodular lymphoma|Brill - Symmers' disease|Lymphoma, Nodular|Follicular low grade B-cell lymphoma|Follicular Non-Hodgkin Lymphoma|Brill Symmers Disease|follicular lymphoma|Follicular non-Hodgkin lymphoma|giant follicular lymphoma|Follicular low grade B-cell lymphoma (disorder)|Follicular lymphoma|Malignant lymphoma, lymphocytic, nodular, NOS|Nodular lymphosarcoma|Nodular and Follicular Lymphomas|Malignant lymphoma, follicle centre, follicular|lymphosarcoma follicular|Follicular non-Hodgkin's lymphoma (disorder)|Follicular non-Hodgkin's lymphoma|Lymphocytic lymphoma, nodular|Follicular lymphosarcoma|Malignant lymphoma, follicle center|Nodular Lymphoma | Lymphoma, Follicular |
C0229664 | A tissue with red blood cells, white blood cells, platelets, and other substances suspended in fluid called plasma. Blood takes oxygen and nutrients to the tissues, and carries away wastes. | Whole Blood|Peripheral Blood|Blood|Reticuloendothelial System, Blood|Peripheral blood|peripheral blood|blood peripheral|BLOOD|blood|Peripheral blood, NOS|Peripheral blood (substance) | peripheral blood |
C0030016 | The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) | Oxidoreductase, NOS|reductase|oxidoreductases|Dehydrogenase|Dehydrogenases|Reductase|OXIDOREDUCTASES|Substance with dehydrogenase mechanism of action|EC 1|dehydrogenase|Reductase (substance)|Reductases|Substance with oxidoreductase mechanism of action (substance)|Substance with dehydrogenase mechanism of action (substance)|Oxidoreductase|oxidoreductase|Oxidoreductases | Oxidoreductase |
C0013570 | An infectious dermatitis of sheep and goats, affecting primarily the muzzle and lips. It is caused by a poxvirus and may be transmitted to man. | ECTHYMA CONTAGIOSUM|orf|Ecthyma contagiosum|contagious ecthyma|Contagious Pustular Dermatitis|Contagious ovine ecthyma|Sore mouth (ovine)|Orf virus disease|ORF|Orf Virus Infections|Orf virus disease (disorder)|Contagious Ecthyma|Ecthyma, Contagious|Virus Infections, Orf|Dermatitis, Contagious Pustular|Orf Virus Infection|Virus Infection, Orf|Contagious ecthyma of sheep|Contagious pustular dermatitis|Pustular Dermatitides, Contagious|Contagious Pustular Dermatitides|Contagious pustular stomatitis|Bovine pustular stomatitis|Dermatitides, Contagious Pustular|Contagious ecthyma|Pustular Dermatitis, Contagious|ECTHYMA INFECTIOSUM|Infections, Orf Virus|Orf|DERMATITIS, PUSTULAR, CONTAGIOUS|Sore mouth [ovine]|Infection, Orf Virus | Ecthyma, Contagious |
C0054498 | null | Caldesmon kinase|Caldesmon kinase (substance)|Ca2+-calmodulin-dependent caldesmon kinase | caldesmon kinase |
C0056588 | null | cumyl hydroperoxide|cumylhydroperoxide|isopropyl benzene hydroperoxide|alpha, alpha- dimethylbenzyl hydroperoxide | cumene hydroperoxide |
C0056588 | null | cumyl hydroperoxide|cumylhydroperoxide|isopropyl benzene hydroperoxide|alpha, alpha- dimethylbenzyl hydroperoxide | cumene hydroperoxide |
C0076150 | A direct-acting oxidative stress-inducing agent used to examine the effects of oxidant stress on Ca(2+)-dependent signal transduction in vascular endothelial cells. It is also used as a catalyst in polymerization reactions and to introduce peroxy groups into organic molecules. | t-Butyl Hydroperoxide|Hydroperoxide, 1,1-dimethylethyl|tert Butyl Hydroperoxide|Hydroperoxide, tert-Butyl|t-Butylhydroperoxide|t Butylhydroperoxide|tert Butylhydroperoxide|tert-Butyl Hydroperoxide|tertiary Butylhydroperoxide|Hydroperoxide, t-Butyl|tertiary-Butylhydroperoxide|t Butyl Hydroperoxide | tert-Butylhydroperoxide |
C0076150 | A direct-acting oxidative stress-inducing agent used to examine the effects of oxidant stress on Ca(2+)-dependent signal transduction in vascular endothelial cells. It is also used as a catalyst in polymerization reactions and to introduce peroxy groups into organic molecules. | t-Butyl Hydroperoxide|Hydroperoxide, 1,1-dimethylethyl|tert Butyl Hydroperoxide|Hydroperoxide, tert-Butyl|t-Butylhydroperoxide|t Butylhydroperoxide|tert Butylhydroperoxide|tert-Butyl Hydroperoxide|tertiary Butylhydroperoxide|Hydroperoxide, t-Butyl|tertiary-Butylhydroperoxide|t Butyl Hydroperoxide | tert-Butylhydroperoxide |
C0031180 | A group of compounds that contain a bivalent O-O group, i.e., the oxygen atoms are univalent. They can either be inorganic or organic in nature. Such compounds release atomic (nascent) oxygen readily. Thus they are strong oxidizing agents and fire hazards when in contact with combustible materials, especially under high-temperature conditions. The chief industrial uses of peroxides are as oxidizing agents, bleaching agents, and initiators of polymerization. (From Hawley's Condensed Chemical Dictionary, 11th ed) | peroxides|peroxide|Peroxides|Peroxide|Peroxide (substance) | Peroxides |
C0014806 | A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. | Product containing erythromycin (medicinal product)|Erythromycin base|érythromycine|Erythromycin-containing product|Erythromycin|Erythromycinum|erythromycins|Erythromycin (substance)|ERYTHROMYCIN|Eritromicina|Erythromycin A|3''-O-demethylerythromycin|Erythromycin, NOS|erythromycin|ERYTHROMYCINS|Abomacetin|erythromycin base | erythromycin |
C0076934 | Enzymes that recombine DNA segments by a process which involves the formation of a synapse between two DNA helices, the cleavage of single strands from each DNA helix and the ligation of a DNA strand from one DNA helix to the other. The resulting DNA structure is called a Holliday junction which can be resolved by DNA REPLICATION or by HOLLIDAY JUNCTION RESOLVASES. | Transposases|transposase|Transposase | Transposase |
C0017428 | The genetic complement of an organism, including all of its GENES, as represented in its DNA, or in some cases, its RNA. | Genome, NOS|Genomic|genome|genomes|Genomes|Genome (substance)|Genome | Genome |
C0015811 | The longest and largest bone of the skeleton, it is situated between the hip and the knee. | FEMUR|Structure of femur|femur|Femurs|Femoral (qualifier value)|BONE, FEMUR|femoral|femurs|Os femoris|Femur, NOS|thigh bone|Femur|Bone structure of femur (body structure)|Bone structure of femur|Structure of femur (body structure)|Femoral|Thigh bone|Bone, Femoral | Femur |
C0184898 | An intentional cut made to an individual's body with the intent of performing a diagnostic or therapeutic intervention. | otomy|Surgical incisions|Incisions|Incision - attribute|Incision, NOS (-otomy)|-otomy|incision|INCISIONS|surgical incisions|Incision (procedure)|Incision, NOS|Incision - attribute (attribute)|surgical incision|Otomy|Incisional|Incision|Surgical Incision | Surgical incisions |
C0054412 | A cadmium halide in the form of colorless crystals, soluble in water, methanol, and ethanol. It is used in photography, in dyeing, and calico printing, and as a solution to precipitate sulfides. (McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) | Cadmium chloride (in water) (substance)|Cadmium chloride (in water)|Dichloride, Cadmium|Chloride, Cadmium|Cadmium Chloride|Cadmium chloride (substance)|Cadmium chloride|Cadmium Dichloride|CADMIUM CHLORIDE|Cadmium chloride (CdCl2)|CdCl2 | cadmium chloride |
C0242696 | The shaft of long bones. | bone shaft|Shaft of long bone|Diaphysis of bone|Body of long bone|Diaphyses|bone diaphysis|Diaphysis of the Bone|Structure of diaphysis (body structure)|Diaphysis, NOS|Shaft of bone, NOS|Diaphysis|Structure of diaphysis|Diaphysis structure|bones long shaft|diaphysis|diaphyses|Shaft of bone | Diaphyses |
C0684164 | null | cholinergic systems|cholinergic system | cholinergic system |
C0028263 | Any sound which is unwanted or interferes with HEARING other sounds. | Signal Noise|noise|noises|Data Noise|noise (sound)|Noise|Noises | Noise |
C0024776 | An autosomal recessive inherited disorder with multiple forms of phenotypic expression, caused by a defect in the oxidative decarboxylation of branched-chain amino acids (AMINO ACIDS, BRANCHED-CHAIN). These metabolites accumulate in body fluids and render a "maple syrup" odor. The disease is divided into classic, intermediate, intermittent, and thiamine responsive subtypes. The classic form presents in the first week of life with ketoacidosis, hypoglycemia, emesis, neonatal seizures, and hypertonia. The intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting. (From Adams et al., Principles of Neurology, 6th ed, p936) | Branched Chain Ketoaciduria|BCKD Deficiency|msud|Branched-Chain Ketoacidurias|Ketoacid decarboxylase deficiency|Branched chain ketoaciduria|Branched-Chain alpha-Keto Acid Dehydrogenase Deficiency|ketoacidemia|Ketoaciduria, Branched-Chain|Maple Syrup Urine Disease|MSUD (Maple Syrup Urine Disease)|Branched chain ketoacid dehydrogenase deficiency|MSUD|KETO ACID DECARBOXYLASE DEFICIENCY|MSU|maple syrup disease|Branched-chain alpha-keto acid dehydrogenase deficiency|BRANCHED-CHAIN KETOACIDURIA|branched chain ketoaciduria|Maple syrup urine disease, NOS|Ketoacidaemia|BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE DEFICIENCY|Ketoacidurias, Branched-Chain|msu|BCKD - Branched chain alpha-ketoacid dehydrogenase deficiency|Maple syrup urine disease|branched-chain ketoaciduria|BCKD deficiency|Oxo-acid decarboxylase deficiency|Branched Chain alpha Keto Acid Dehydrogenase Deficiency|MAPLE SYRUP URINE DISEASE|disease maple syrup urine|Ketoacidemia|BCKD DEFICIENCY|MSUD - Maple syrup urine disease|Branched-Chain Ketoaciduria|Maple syrup urine disease (disorder)|BRANCHED-CHAIN KETONURIA|maple syrup urine disease|Keto Acid Decarboxylase Deficiency | Maple Syrup Urine Disease |
C0001898 | A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. | (L)-Alanine|(S)-alanine|Alaninum|L-alanine|alanine|Alpha-aminopropionic acid|L-α-alanine|Alanina|L-Isomer Alanine|ALANINE|ala|Alanine|L-alpha-Alanine|(S)-2-Aminopropanoic acid|l-alanine|(2S)-2-aminopropanoic acid|Ala|L Alanine|L-2-Aminopropionic acid|Alanine, L-Isomer|l alanine|Alanine, L Isomer|Alanine (substance)|L-Alanine|2-aminopropionic acid|(S)-2-aminopropanoic acid|L-Alanin | alanine |
C0019602 | An essential amino acid that is required for the production of HISTAMINE. | His|L-Histidine|HISTIDINE|(S)-2-Amino-3-(1H-imidazol-4-yl)propanoic acid|HIS|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-histidine|Histidina|(S)-alpha-Amino-1H-imidazole-4-propionic acid|L-(-)-histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid|Histidine, L-isomer|L-Histidin|Histidine (substance)|l histidine|L-isomer Histidine|histidine|Histidine|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|Histidine, L isomer|(S)-α-amino-1H-Imidazole-4-propanoic acid|l-Histidine|l-histidine | histidine |
C0024337 | An essential amino acid. It is often added to animal feed. | 6-ammonio-L-norleucine|(S)-α,ε-diaminocaproic acid|lysine|L-alpha,epsilon-Diaminocaproic Acid|Lys|Lysinum|Lysine-containing product|LYSINE|L-Lysine|(S)-2,6-Diaminohexanoic acid|LYS|lys|(S)-2,6-diaminohexanoic acid|L-Lysin|(S)-lysine|Lysina|l lysine|l-lysine|Lysine (substance)|L Lysine|L-lysine|Lysine acid|Product containing lysine (medicinal product)|Lysine|L-2,6-Diaminocaproic acid|L-alpha,epsilon-diaminocaproic acid|L-lys | lysine |
C0025646 | A sulfur-containing essential L-amino acid that is important in many body functions. | Racemethionine-containing product|Methionine, L-Isomer|L-(-)-methionine|L-Methionine|L-α-amino-γ-methylmercaptobutyric acid|Methionine-containing product|l-methionine|L-Methionin|(S)-2-amino-4-(methylthio)butanoic acid|Met|L-Isomer Methionine|Methionine|(S)-2-amino-4-(methylthio)butyric acid|(2S)-2-amino-4-(methylsulfanyl)butanoic acid|Product containing methionine (medicinal product)|METHIONINE|L-a-Amino-g-methylthiobutyric acid|L-methionine (substance)|M|methionine|(S)-methionine|Methionine, L Isomer|L-methionine|(S)-2-Amino-4-(methyl-sulfanyl)butanoic acid|l methionine | methionine |
C0029277 | An amino acid produced in the urea cycle by the splitting off of urea from arginine. | Ornithine (substance)|ORNITHINE|ornithine|Ornithine|Ornithinum|Ornitina|2,5 Diaminopentanoic Acid|2,5-Diaminopentanoic Acid | ornithine |
C0031453 | An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. | phe|F|(S)-alpha-Amino-beta-phenylpropionic acid|Fenilalanina|Phe|Phenylalanine (substance)|Phenylalanine-containing product|l-phenylalanine|β-phenyl-L-alanine|L-Phenylalanine|2-Amino-3-phenyl-pronanoic acid|3-phenyl-L-alanine|beta-Phenyl-L-alanine|PHENYLALANINE|phenylalanine|L-phenylalanine|Phenylalanine, L Isomer|L-Isomer Phenylalanine|Phenylalanine|Product containing phenylalanine (medicinal product)|PHE - phenylalanine|Phenylalanine, L-Isomer|(S)-2-Amino-3-phenylpropionic acid|Phenylalaninum | phenylalanine |
C0041485 | A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. | L-tyrosine|Y|tyrosine (Tyr)|Tyrosine, L isomer|TYROSINE, (L)|l tyrosine|Tirosina|Tyrosinum|(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid|TYR|L-Tyrosin|Tyr|(S)-Tyrosine|(S)-2-Amino-3-(4-hydroxy-phenyl)propanoic acid|para Tyrosine|4-hydroxy-L-phenylalanine|Tyrosine|(S)-(-)-Tyrosine|para-Tyrosine|Tyrosine (substance)|TYROSINE|tyrosine|L Tyrosine|(-)-α-amino-p-hydroxyhydrocinnamic acid|l-tyrosine|Tyrosine, L-isomer|L-Phenylalanine, 4-hydroxy-|Product containing tyrosine (medicinal product)|(S)-alpha-amino-4-Hydroxybenzenepropanoic acid|(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid|(S)-3-(p-Hydroxyphenyl)alanine|tyr|(S)-α-amino-4-hydroxybenzenepropanoic acid|L-Tyrosine|Tyrosine-containing product | tyrosine |
C0041249 | An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals. | L-β-3-indolylalanine|(S)-alpha-Amino-beta-(3-indolyl)-propionic acid|l tryptophan|l-tryptophan|Tryptophan (substance)|Tryptophane|L-tryptophan|Tryptophan|L-(-)-Tryptophan|Triptofano|Tryptophan-containing product|(S)-2-Amino-3-(1H-indol-3-yl)-propanoic acid|tryptophan|(S)-Tryptophan|Trp|(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid|Product containing tryptophan (medicinal product)|W|tryptophane|(S)-α-amino-1H-indole-3-propanoic acid|L Tryptophan|trp|L-Tryptophan|Levotryptophan|Tryptophanum|tryptophan (Trp)|L-TRYPTOPHAN|TRYPTOPHAN|L-(-)-tryptophan | tryptophan |
C0022192 | An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of LEUCINE. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels. | α-amino-β-methylvaleric acid|Isoleucine|ile|isoleucine|Isoleucine, L-Isomer|Product containing isoleucine (medicinal product)|Isoleucine, L Isomer|L-Isoleucine|ISOLEUCINE|Isoleucina|Ile|iles|alpha-amino-beta-methylvaleric acid|2-Amino-3-methylvaleric acid|L-Isomer Isoleucine|Isoleucine (substance)|Isoleucinum|Ile - Isoleucine|Isoleucine-containing product|(2S,3S)-2-Amino-3-methylpentanoic acid|L-isoleucine | isoleucine |
C0023401 | An essential branched-chain amino acid important for hemoglobin formation. | Product containing leucine (medicinal product)|leu|L-Leuzin|(2S)-alpha-Leucine|(S)-Leucine|L|L-Leucine|Leucine (substance)|L-Leucin|(S)-2-Amino-4-methylpentanoic acid|leucine (Leu)|Leucine-containing product|l-leucine|(2S)-alpha-2-Amino-4-methylvaleric acid|Leu|leucine|Leucine, L-Isomer|L-Isomer Leucine|2-Amino-4-methylvaleric acid|(S)-(+)-Leucine|Leucine|L-leucine|LEUCINE|(2S)-2-Amino-4-methylpentanoic acid|Leucine, L Isomer | leucine |
C0042285 | A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway. | (2S)-2-Amino-3-methylbutanoic acid|Valine|L-(+)-alpha-Aminoisovaleric acid|(S)-2-Amino-3-methylbutanoic acid|valine (VAL)|Product containing valine (medicinal product)|valine|l-valine|2-Amino-3-methylbutyric acid|(S)-Valine|L Valine|L-alpha-Amino-beta-methylbutyric acid|Val|L-valin|L-Valine|Valine (substance)|VALINE|L-valine|Valine-containing product | valine |
C0034693 | The common rat, Rattus norvegicus, often used as an experimental organism. | rat|Norway rat|Rattus norvegicus|rats|Wild rat|brown rat|RATTUS NORVEGICUS|Old World rat|Brown rat|Norway Rat|norway rat|Common Rat|Rattus norvegicus (organism)|Rats, Norway|Rat|Rat, NOS|Rats | Rattus norvegicus |
C0740391 | null | Occlusion, Middle Cerebral Artery|Middle cerebral artery occlusion|Middle cerebral artery occlusion (disorder) | Middle Cerebral Artery Occlusion |
C1269012 | null | Entire MCA - Middle cerebral artery|Entire middle cerebral artery|Entire middle cerebral artery (body structure) | Entire middle cerebral artery |
C0038525 | Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status. | Subarachnoid Hemorrhage|SAH - Subarachnoid hemorrhage|Hemorrhages, Subarachnoid|SAHs (Subarachnoid Hemorrhage)|subarachnoid hemorrhage|hemorrhage subarachnoid|Subarachnoid intracranial hemorrhage|SUBARACHNOID HEMORRHAGE|SAH - Subarachnoid haemorrhage|Subarachnoid Hemorrhages|SUBARACHNOID HAEMORRHAGE|Subarachnoid hemorrhage|Subarachnoid intracranial haemorrhage|subarachnoid haemorrhage|Subarachnoid intracranial hemorrhage (disorder)|SAH (Subarachnoid Hemorrhage)|HEMORRHAGE SUBARACHNOID|Subarachnoid haemorrhage|subarachnoid hemorrhages|Hemorrhage, Subarachnoid | Subarachnoid Hemorrhage |
C0814997 | null | intestinal cell|cells intestinal | Intestinal cell |
C1519106 | A rodent disease whose pathologic mechanisms are sufficiently similar to those of a human disease to serve as a model. | null | Rodent Model of Disease |
C0009324 | Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. | Ulcerative colitis as reason for lower g.i. examination|Idiopathic proctocolitis|COLITIS, ULCERATIVE|ULCERATIVE COLITIS|COLITIS ULCERATIVE|Colitis Gravis|INFLAMMATORY BOWEL DISEASE ULCERATIVE COLITIS|colitis ulcerative|Colitis gravis|Colitis gravis, NOS|uc|ulcerative colitis|Ulcerative colitis, NOS|Inflammatory Bowel Disease, Ulcerative Colitis Type|Colitis ulcerosa|Idiopathic Proctocolitis|Colitis, Ulcerative|Ulcerative colitis (disorder)|UC - Ulcerative colitis|Colitis Ulcerative|Ulcerative colitis|Ulcerative colitis as main diagnosis for the colon|Ulcerative Colitis|Ulcerative colitis, unspecified | Ulcerative Colitis |
C0699819 | null | Developmental gut|Gut|gut|guts | Gut |
C0004561 | Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. | B-cell|b lymphocytes|b-lymphocyte|B Lymphocytes|b-cell|B lymphocyte|B Cell|B-Lymphocyte|B-Lymphocytes|bursa-equivalent lymphocyte|b cells|B lymphocyte (cell)|Bursa Dependent Lymphocytes|B-Cells|B Cell Lymphocyte|B cell|B-Cell|Lymphocytes, Bursa-Dependent|Bursa-Dependent Lymphocytes|b cell|B-lymphocyte|B Cells|Bursa-Dependent Lymphocyte|b-lymphocytes|b lymphocyte|Lymphocyte, Bursa-Dependent|b-cells|B cells | B-Lymphocytes |
C0004368 | Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. | Autoimmune Status|Autoimmune state|autoimmunity|Autoimmune state (finding)|Autoimmunities|Autoimmunity, NOS|Autoimmunity|Autoimmune state, NOS | Autoimmune state |
C0449719 | One of the portions into which something is regarded as divided and which together constitute a whole. | part|parts|Part (attribute)|Portion|Part | Part |
C0021758 | A soluble factor produced by activated T-LYMPHOCYTES that induces the expression of MHC CLASS II GENES and FC RECEPTORS on B-LYMPHOCYTES and causes their proliferation and differentiation. It also acts on T-lymphocytes, MAST CELLS, and several other hematopoietic lineage cells. | IgE/IgG1 enhancing factor|B cell growth factor|BCSF 1|Mast cell growth factor 2|BAF (B cell activating factor)|B Cell Growth Factor I|B-Cell Proliferating Factor|interleukin-4 (IL-4)|MCGF-2|il-4|BCGF-1|Interleukin 4|B-cell activating factor|B Cell Stimulatory Factor 1|T-cell growth factor 2|B Cell Proliferating Factor|Interleukin-4 (substance)|B Cell Stimulatory Factor-1|Mast Cell Growth Factor 2|TCGF 2|Interleukin-4|B-Cell Stimulatory Factor-1|BCAF|B-Cell Growth Factor-1|B Cell Growth Factor 1|B-cell growth factor|interleukin-4|Mast Cell Growth Factor-2|BCGF (B cell growth factor)|BCGF|MCGF 2|interleukin 4|B cell stimulating factor 1|B-Cell Stimulating Factor-1|B cell activating factor|IL4|BSF1|BSF-1|IL-4|B-cell stimulating factor|B-Cell Stimulatory Factor 1|b cell growth factor|BSF1 (B cell stimulating factor 1)|B Cell Stimulating Factor 1|B-Cell Growth Factor-I | interleukin-4 |
C0051959 | null | 2-aminobenzoic acid | anthranilic acid |
C0051959 | null | 2-aminobenzoic acid | anthranilic acid |
C0205950 | The roof or dome of the skull. | skullcap|calva|Calveria|Cranial vault|BONE, CALVARIUM|skull vault|calvarium|Structure of vault of skull (body structure)|Calva|Skullcap|Structure of vault of skull|calvaria|Vault of skull|Calvarium|Calvaria|Calveria, NOS|Concha of cranium | Calvaria |
C0005955 | Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. | bone marrow cell|Cells, Bone Marrow|Bone Marrow Blood-Forming Cells|bone cell marrow|bone cells marrow|Cell, Bone Marrow|cell bone marrow|Bone Marrow Cell|Bone marrow cell|cells bone marrow|Bone marrow cells|bone marrow cells|Bone Marrow Blood-Forming Cell|Marrow Cell, Bone|Marrow Cells, Bone | Bone Marrow Cells |
C0228505 | null | Lobule X of hemisphere of cerebellum|Neuraxis flocculus|H X|Nodulus cerebelli|nodulus cerebelli|Nodule of vermis of cerebellum|Neuraxis nodulus|Cerebellar nodule (body structure)|Flocculus of cerebellum|Nodulus of vermis of cerebellum|Lobule X of vermis of cerebellum|nodulus|Lobule H X of Larsell|Cerebellar nodule|nodules|Vermian lobule X | Nodulus cerebelli |
C0940933 | null | Complication, infection|complications infections|complications infection|infection complication | infection as a complication |
C0037083 | The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. | Cell Communication and Signaling|Signal Transduction|System, Signal Transduction|Systems, Signal Transduction|cell signaling|biological signal transduction|cells signal|Signal transduction, function (observable entity)|signal transduction|Transduction, Signal|signaling pathway|Signal transduction, function|Signal Transduction Systems|cell signals|Signal transduction|Signal Transductions|Signal Transduction System|signalling pathway|Transductions, Signal|signal cell|Signaling|Intracellular Communication and Signaling|Cell Signaling | Signal Transduction |
C0440744 | index on projects employing indirectly obtained normal or abnormal tissues, body fluids, excretions, cells, biochemicals, etc; sources can include eye and tissue banks, blood banks, surgically excised tissue, or postmortem tissue. | human tissues|humans tissues|human tissue|Human tissue|Human tissue (substance) | Human tissue |
C0450442 | An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. | Agent|Agent (attribute) | Agent |
C0002895 | A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S. | SICKLE CELL DISEASE|SCD|sickle-cell anemia|Sickle Cell Anemias|Anemias, Sickle Cell|Sickle cell syndrome|Sickle Cell Disorders|Sickle cell-hemoglobin SS disease (disorder)|cell sickle syndromes|Hemoglobin S Diseases|sickle-cell disease|Hemoglobin SS disease|Sickle Cell Disease|Hb S disease|Sickle cell-haemoglobin SS disease|Sickling Disorder Due to Hemoglobin S|HERRICK SYNDROME|disease sickle cell|Hb SS disease|sickle cell disorder|Drepanocythaemia|Hemoglobin SS Disease|Sickle-cell anemia NOS|Sickle-cell Disorders|Cell Disorders, Sickle|Hereditary haemoglobinopathy disorder homozygous for haemoglobin S|Cell Disease, Sickle|scds|sickle cell disease|Sickle cell anemia|Sickle cell-hemoglobin SS disease|Sickle cell anaemia|anemia sickle celled|sickle cell anemias|anemia sickle-cell|anaemia cell sickle|Sickling Disorder due to Hemoglobin S|hb s disease|anemia cells sickle|Anemia, Sickle Cell|Hemoglobin S disease|Hemoglobin S Disease|disease sickle-cell|cells disease sickle|sickle cell syndrome|cell sickle syndrome|Sickle-cell disease|HbS Disease|Sickling disorder due to hemoglobin S (disorder)|sickle cell anaemia|Sickle Cell Anemia|anemia sickle cell|sicklemia|anemia cells sickles|Hemoglobin S-S disease|anemia cell disorders sickle|Haemoglobin S disease|Disease, Hemoglobin S|Herrick's anemia|Sickle Cell Diseases|ANEMIA, SICKLE CELL|Haemoglobin S-S disease|Sickle Cell Disorder|syndrome sickle cell|disease hb s|anemia cell disorder sickle|sickle cell anemia|Sickling disorder due to haemoglobin S|SICKLE CELL HEMOLYTIC ANEMIA|Drepanocythemia|Sickle-cell disease, unspecified|Hereditary hemoglobinopathy disorder homozygous for hemoglobin S|Cell Diseases, Sickle|Sickling disorder due to hemoglobin S|Cell Disorder, Sickle|Sickle cell disease|cell disorder sickle|cell diseases sickle|sickle-cell anaemia|SICKLE CELL ANEMIA | Anemia, Sickle Cell |
C0023516 | White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). | WBC (white blood cell)|Reticuloendothelial System, Leukocytes|White Blood Corpuscle|Blood Cell, White|White blood cells|Corpuscles, White Blood|White Cell|Blood Corpuscles, White|Leukocytic|Blood Corpuscle, White|Marrow leukocyte|WBC|Leukocytes|bloods cells white|white blood cell (WBC)|WBC - White blood cell|white blood corpuscle|LEUKOCYTE|Corpuscle, White Blood|White blood cell, NOS|white blood cells|Leukocyte|White Blood Corpuscles|blood white cells|leukocyte|blood leukocytes|White Blood Cells|Leucocytes|blood white cell|Leukocyte, NOS|leukocytes|white blood cell|Blood Cells, White|leucocyte|cell leukocyte|White Blood Cell|leucocytes|blood corpuscles white|Blood leukocyte|Leukocyte (cell)|leukocytic|Leucocyte|White blood cell | Leukocytes |
C0008862 | A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon. | Levinea|Citrobacter|CITROBACTER|Genus Citrobacter (organism)|Citrobacter, NOS|Citrobacter species|Genus Citrobacter|citrobacter | Citrobacter |
C0206131 | Cells in the body that store FATS, usually in the form of TRIGLYCERIDES. WHITE ADIPOCYTES are the predominant type and found mostly in the abdominal cavity and subcutaneous tissue. BROWN ADIPOCYTES are thermogenic cells that can be found in newborns of some species and hibernating mammals. | Fat cell|Adipocyte|adipose cells|Mature fat cell|fat cell|Adipose Cell|lipocytes|Adipocyte (cell)|adipose cell|Fat cells|fat cells|Cell, Fat|Fat Cell|Cells, Fat|adipocytes|Mature Fat Cell|lipocyte|adipocyte|Lipocytes|Mature Lipocyte|Adipose cell|Fat Cells|Lipocyte|Adipocytes | Adipocytes |
C0036341 | A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. | schizophrenia disorder|Schizophrenia|Schizophrenic Disorder|disorder schizophrenia|Schizophrenia, NOS|schizophrenias|Dementia Praecox|Unspecified schizophrenia|disorders schizophrenia|unspecified schizophrenia|Unspecified schizophrenia, unspecified|SCHIZOPHRENIA|schizophrenic disorder|SCZD|schizophrenia type|SCHIZOPHRENIAS|Schizophrenias|Dementia praecox|Schizophrenic disorders (disorder)|Schizophrenic disorders|Unspecified schizophrenia, unspecified state|Disorder, Schizophrenic|disorder schizophrenic|Disorders, Schizophrenic|disorders schizophrenic|schizophrenia|Schizophrenic Disorders|schizophrenic disorders|Schizophrenia NOS|dementia praecox|Schizophrenia (disorder)|schizophrenia types|disorders schizophrenics|type schizophrenia | Schizophrenia |
C0314657 | A latent susceptibility to disease at the genetic level, which may be activated under certain conditions. | Susceptibilities, Genetic|genetic predisposition|Genetic Susceptibilities|Genetic predisposition|Predisposition, Genetic|Genetic predisposition (finding)|Susceptibility, Genetic|Predispositions, Genetic|genetic predispositions|Inherited Predisposition|genetics predisposition|Genetic Susceptibility|genetic susceptibility|Genetic Predispositions|Genetic Predisposition|Inherited Susceptibility | Genetic Predisposition to Disease |
C0018909 | Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. | Hemagglutinin, NOS|Haemagglutinin, NOS|haemagglutinin|Haemagglutinin|hemagglutinins|Hemagglutinin|hemagglutinin|Hemagglutinins | Hemagglutinin |
C0029343 | A subtype of type A influenza virus found chiefly in birds, but infections with these viruses can occur in humans. | avian flu virus|Pestis galli Myxoviruses|Influenza virus type A, avian|avian influenza virus|Avian Orthomyxovirus Type A|Myxovirus pestis galli|Fowl Plague Virus|Fowl Plague Viruses|Virus, Fowl Plague|Plague Viruses, Fowl|Myxovirus, Pestis galli|Avian Influenza Virus|Viruses, Fowl Plague|Influenzavirus, type A, avian|Fowl plague virus|Avian Influenza A Virus|Pestis galli Myxovirus|Avian influenza A virus|Bird Flu Virus|Plague Virus, Fowl|Myxoviruses, Pestis galli|fowl plague virus FPV|bird flu virus|Orthomyxovirus Type A, Avian | Influenza A Virus, Avian |
C0034861 | Proteins prepared by recombinant DNA technology. | Recombinant protein (substance)|protein recombinant|recombinant protein|Recombinant proteins|Proteins, Biosynthetic|recombinant proteins|protein recombinants|Proteins, Recombinant|Recombinant protein|Recombinant Protein|Biosynthetic Proteins | Recombinant Proteins |
C0040669 | The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. | Transfections|transfection|Transfection | Transfection |
C0035191 | A thick substance that comes from plants or can be made in the laboratory from certain chemicals. Resins do not dissolve in water, and are used in plastics, varnishes, printing inks, medicine, and to make fabrics stiff. | Plant Hydrocarbon Secretion|Resins, Plant|Plant Resins|Resina|Resin|resins|resin | Resins, Plant |
C0019369 | A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE. | Virus-Herpes|Herpes Virus|Herpesvirus group|Herpesvirus|herpes virus group|Family Herpesviridae (organism)|Family Herpesviridae|Herpesviruses|Herpetoviridae|Herpes group virus|herpetoviridae|Herpesviridae|herpesviruses|Herpes virus group|herpesviridae|herpesvirus | Herpesviridae |
C0206580 | A genus of the family POXVIRIDAE, subfamily CHORDOPOXVIRINAE, comprising many species infecting mammals. Viruses of this genus cause generalized infections and a rash in some hosts. The type species is VACCINIA VIRUS. | Vaccinia subgroup, NOS|Orthopoxvirus, NOS|Orthopoxvirus|Vaccinia subgroup virus|Orthopoxviruses|ORTHOPOXVIRUS|Orthopoxvirus species|orthopoxvirus|Vaccinia subgroup|Genus Orthopoxvirus (organism)|Genus Orthopoxvirus|orthopoxviruses | Orthopoxvirus |
C0040078 | An enzyme that catalyzes the conversion of ATP and thymidine to ADP and thymidine 5'-phosphate. Deoxyuridine can also act as an acceptor and dGTP as a donor. (From Enzyme Nomenclature, 1992) EC 2.7.1.21. | Thymidine kinase (substance)|EC 2.7.1.21|Kinase, Thymidine|Thymidine kinase|thymidine kinase|Kinase, Deoxypyrimidine|Kinase, Deoxythymidine|ATP:thymidine 5'-phosphotransferase|Deoxypyrimidine Kinase|Deoxythymidine Kinase|Thymidine Kinase | Thymidine Kinase |